PT2153260T - Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma - Google Patents
Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesmaInfo
- Publication number
- PT2153260T PT2153260T PT87562112T PT08756211T PT2153260T PT 2153260 T PT2153260 T PT 2153260T PT 87562112 T PT87562112 T PT 87562112T PT 08756211 T PT08756211 T PT 08756211T PT 2153260 T PT2153260 T PT 2153260T
- Authority
- PT
- Portugal
- Prior art keywords
- processes
- preparation
- composition
- same
- biologically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M1/00—Apparatus for enzymology or microbiology
- C12M1/12—Apparatus for enzymology or microbiology with sterilisation, filtration or dialysis means
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/20—Partition-, reverse-phase or hydrophobic interaction chromatography
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Sustainable Development (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93979207P | 2007-05-23 | 2007-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2153260T true PT2153260T (pt) | 2017-04-24 |
Family
ID=39669869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT87562112T PT2153260T (pt) | 2007-05-23 | 2008-05-23 | Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US20090004716A1 (pt) |
| EP (1) | EP2153260B1 (pt) |
| JP (1) | JP5793726B2 (pt) |
| KR (1) | KR101497728B1 (pt) |
| CN (2) | CN101702938A (pt) |
| AU (1) | AU2008256681B2 (pt) |
| CA (1) | CA2685069C (pt) |
| ES (1) | ES2622418T3 (pt) |
| HR (1) | HRP20170233T1 (pt) |
| PT (1) | PT2153260T (pt) |
| WO (1) | WO2008148010A1 (pt) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101909635B (zh) | 2008-01-11 | 2014-09-17 | Vgx药品有限责任公司 | 针对多种登革病毒亚型的新颖疫苗 |
| US7932356B1 (en) * | 2010-06-23 | 2011-04-26 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
| EP2632261B1 (en) | 2010-10-26 | 2016-07-13 | Presidio Pharmaceuticals, Inc. | Inhibitors of hepatitis c virus |
| EA202092990A3 (ru) | 2011-02-11 | 2021-07-30 | Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания | Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу |
| US9238679B2 (en) | 2011-02-11 | 2016-01-19 | The Trustees Of The University Of Pennslyvania | Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same |
| US10883100B2 (en) * | 2011-03-29 | 2021-01-05 | Phynexus, Inc | Devices and methods for plasmid purification |
| US11274292B2 (en) | 2011-03-29 | 2022-03-15 | Phynexus, Inc. | Devices and methods for plasmid purification |
| CN102212466B (zh) * | 2011-04-11 | 2013-08-28 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 制备质粒dna的碱裂解系统及组合系统 |
| JP6117781B2 (ja) | 2011-07-11 | 2017-04-19 | イノビオ ファーマシューティカルズ,インコーポレイティド | 交差防御性アレナウイルスワクチンおよびそれらの使用方法 |
| US9556427B2 (en) * | 2013-02-27 | 2017-01-31 | Syngenta Participations Ag | Methods and compositions for preparation of nucleic acids |
| KR20150130284A (ko) | 2013-03-15 | 2015-11-23 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 암 백신 및 이를 이용한 치료 방법 |
| KR101718045B1 (ko) * | 2015-09-07 | 2017-03-20 | 엘지전자 주식회사 | 스크롤 압축기 |
| CA3013718C (en) | 2016-02-05 | 2023-09-26 | Jian Yan | Cancer vaccines and methods of treatment using the same |
| AU2018383663B2 (en) | 2017-12-13 | 2023-12-21 | Inovio Pharmaceuticals, Inc. | Cancer vaccines targeting BORIS and uses thereof |
| CN111741772A (zh) | 2017-12-13 | 2020-10-02 | 艾诺奥医药品有限公司 | 靶向muc16的癌症疫苗和其用途 |
| MX2020006226A (es) | 2017-12-13 | 2020-11-18 | Inovio Pharmaceuticals Inc | Vacunas contra el cancer dirigidas a mesotelina y usos de estas. |
| CA3083532C (en) | 2017-12-13 | 2023-09-05 | Inovio Pharmaceuticals, Inc. | Cancer vaccines targeting prame and uses thereof |
| TWI903214B (zh) * | 2018-05-02 | 2025-11-01 | 美商里珍納龍藥品有限公司 | 用於評估生化過濾器的適合性的方法 |
| MX2020012910A (es) * | 2018-05-31 | 2021-05-27 | Vgxi Inc | Aparato de espiral de lisis y usos del mismo para el aislamiento y purificacion de polinucleotidos. |
| EP3594338A1 (en) * | 2018-07-12 | 2020-01-15 | Kaneka Eurogentec SA | Method and apparatus for the purification of extra-chromosomal nucleic acid sequences |
| CN115404154A (zh) * | 2021-05-10 | 2022-11-29 | 艾棣维欣(苏州)生物制品有限公司 | 用于提取细菌中质粒dna的装置 |
| CN114933960A (zh) * | 2022-07-03 | 2022-08-23 | 苏州谱博分析技术有限公司 | 一种连续流细菌破碎与澄清装置 |
| CN116855359A (zh) * | 2023-07-11 | 2023-10-10 | 江苏谱新生物医药有限公司 | 一种质粒碱裂解的系统和方法 |
| JP2026006022A (ja) * | 2024-06-28 | 2026-01-16 | キヤノン株式会社 | 細胞処理方法、及び細胞処理装置 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6197553B1 (en) * | 1994-07-15 | 2001-03-06 | Merck & Co., Inc. | Method for large scale plasmid purification |
| AR003122A1 (es) * | 1995-05-19 | 1998-07-08 | Merck & Co Inc | Un proceso para aislacion y purificacion de plasmidos en fermentadores de gran escala y el adn aislado y purificado obtenido mediante dicho proceso. |
| WO2001046215A1 (en) * | 1999-12-22 | 2001-06-28 | Merck & Co., Inc. | Process for the scaleable purification of plasmid dna |
| PT102491B (pt) * | 2000-07-10 | 2003-02-28 | Inst Superior Tecnico | Processo para producao e purificacao de dna plasmidico |
| US20030197936A1 (en) * | 2002-04-18 | 2003-10-23 | The Board Of Trustees Of The Leland Stanford Junior University | Tunable polarization mode dispersion compensation using multi-layered reflector |
| GB0210899D0 (en) * | 2002-05-13 | 2002-06-19 | Aston Photonic Tech Ltd | Dispersion compensator |
| CA2498518A1 (en) * | 2002-09-13 | 2004-03-25 | Valentis, Inc. | Apparatus and method for preparative scale purification of nucleic acids |
| EP1462519A1 (en) * | 2003-03-24 | 2004-09-29 | Boehringer Ingelheim Austria GmbH | Method and devices for producing biomolecules |
| ES2748130T3 (es) * | 2003-05-30 | 2020-03-13 | Vgxi Inc | Dispositivos y métodos para la producción de un biomaterial |
| US7221827B2 (en) * | 2003-09-08 | 2007-05-22 | Aegis Semiconductor, Inc. | Tunable dispersion compensator |
| JP2007505613A (ja) * | 2003-09-17 | 2007-03-15 | センテリオン | 医薬品グレードのプラスミドdnaの作成方法 |
| SE0400490D0 (sv) * | 2004-02-26 | 2004-02-26 | Amersham Biosciences Ab | Plasmid purification |
| NZ549835A (en) * | 2004-04-19 | 2008-12-24 | Centelion | Method for purifying plasmid DNA |
| CN100439497C (zh) * | 2006-05-26 | 2008-12-03 | 吉林大学 | 一种适用于大规模生产质粒dna的纯化方法 |
-
2008
- 2008-05-23 CN CN200880016945A patent/CN101702938A/zh active Pending
- 2008-05-23 CA CA2685069A patent/CA2685069C/en active Active
- 2008-05-23 US US12/126,611 patent/US20090004716A1/en not_active Abandoned
- 2008-05-23 CN CN201510489734.5A patent/CN105567672A/zh active Pending
- 2008-05-23 WO PCT/US2008/064726 patent/WO2008148010A1/en not_active Ceased
- 2008-05-23 EP EP08756211.2A patent/EP2153260B1/en active Active
- 2008-05-23 KR KR1020097026603A patent/KR101497728B1/ko active Active
- 2008-05-23 ES ES08756211.2T patent/ES2622418T3/es active Active
- 2008-05-23 HR HRP20170233TT patent/HRP20170233T1/hr unknown
- 2008-05-23 AU AU2008256681A patent/AU2008256681B2/en active Active
- 2008-05-23 PT PT87562112T patent/PT2153260T/pt unknown
- 2008-05-23 JP JP2010509572A patent/JP5793726B2/ja active Active
-
2019
- 2019-07-22 US US16/517,985 patent/US11453855B2/en active Active
-
2022
- 2022-09-06 US US17/903,751 patent/US20230002720A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP2153260B1 (en) | 2017-01-25 |
| US20090004716A1 (en) | 2009-01-01 |
| HRP20170233T1 (hr) | 2017-06-02 |
| WO2008148010A1 (en) | 2008-12-04 |
| CN101702938A (zh) | 2010-05-05 |
| KR20100017884A (ko) | 2010-02-16 |
| US20200017819A1 (en) | 2020-01-16 |
| AU2008256681A1 (en) | 2008-12-04 |
| JP5793726B2 (ja) | 2015-10-14 |
| AU2008256681B2 (en) | 2014-07-31 |
| US11453855B2 (en) | 2022-09-27 |
| WO2008148010A9 (en) | 2013-10-24 |
| WO2008148010A8 (en) | 2010-02-18 |
| CA2685069A1 (en) | 2008-12-04 |
| ES2622418T3 (es) | 2017-07-06 |
| CA2685069C (en) | 2019-01-15 |
| CN105567672A (zh) | 2016-05-11 |
| JP2010527617A (ja) | 2010-08-19 |
| EP2153260A1 (en) | 2010-02-17 |
| KR101497728B1 (ko) | 2015-03-03 |
| US20230002720A1 (en) | 2023-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2153260T (pt) | Composição que compreende uma alta concentração de moléculas biologicamente ativas e processos de preparação da mesma | |
| BRPI0815079A2 (pt) | Composto dericado de 1,2-diamido-etileno, composição farmacêutica que contém e uso desse composto | |
| EP2131848A4 (en) | COMPOSITIONS AND METHODS FOR REINFORCED ACTIVITY OF BIOLOGICAL ACTIVE MOLECULES | |
| BRPI1011876A2 (pt) | "composição farmacêutica estável e métodos de uso da mesma" | |
| BRPI0810744A2 (pt) | Moléculas absorventes de oxigênio, objetos que as contêm, e métodos de sua utilização | |
| EP2191826A4 (en) | PHARMACEUTICAL COMPOSITION | |
| BRPI0717699A2 (pt) | "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição! | |
| BRPI0916235A2 (pt) | composto, composição farmacêutica, uso do composto ou da composição, e, método para tratar um paciente infectado com hcv | |
| BRPI0820665A2 (pt) | compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos | |
| BRPI0809667A2 (pt) | Composto, medicamento e composição farmacêutica que o contém e uso do composto | |
| BRPI0920955A2 (pt) | processo para a preparação de uma composição polimérica , composição polimérica, misturas, e, uso da composição polimérica | |
| EP2054405A4 (en) | New biarylbenzimidazole derivatives and pharmaceutical composition containing them | |
| BRPI0917001A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou uma composição farmacêutica | |
| EP2475649A4 (en) | INDENO DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREWITH | |
| BRPI0908208A2 (pt) | Composto derivado de oxazolidinona, medicamento, composição farmacêutica que o contém e uso desse composto. | |
| CL2007003672A1 (es) | Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad. | |
| FR2926996B1 (fr) | Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine | |
| BRPI0821327A2 (pt) | Derivado de catecol, composição farmacêutica contendo o mesmo, uso do derivado de catecol, e uso da composição farmacêutica | |
| BRPI0905687A2 (pt) | "composto da fórmula i ou i', composição farmacêutica, método de tratamento de um paciente com uma doença, uso do composto" | |
| CL2007002619A1 (es) | Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion. | |
| BR112013014189A2 (pt) | composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções | |
| BRPI0916571A2 (pt) | composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto | |
| CL2009000665A1 (es) | Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas. | |
| BRPI0720323A2 (pt) | composto, método de tratamento, composição farmacêutica e uso do composto | |
| DE602008005137D1 (de) | Chinolonverbindung und pharmazeutische zusammensetzung |